From: Optimization of ectopic gene expression in skeletal muscle through DNA transfer by electroporation
Group # | Limb | Injection | EP | Electrode Type | Mean % β-Gal expressiona (+/- SD) | Mean % Area of Muscle Damage (+/- SD) |
---|---|---|---|---|---|---|
1 | Left | IA CMVLacZ in 0.9% Saline | No EP | No EP | 0.0475b ± 0.0377 | |
2 | Right | IA CMVLacZ in 0.9% Saline | + | A | 0.4900h ± 0.0200 | |
3 | Left | IM CMVLacZ in 0.9% Saline | No EP | No EP | 0.0200b ± 0.0082 | |
4 | Right | IM CMVLacZ in 0.9% Saline | + | A | 7.790c,e ± 4.5254 | 5.6 ± 4.9 |
5 | Right | IM CMVLacZ in 0.9% Saline | + | B | 5.04c,d,f ± 2.4683 | 8.5 ± 4.9 |
6 | Right | IM CMVLacZ in 0.9% Saline | + | C | 3.6167d ± 2.2234 | 21.3 ± 6.1 |
7 | Right | IM CMVLacZ in 0.9% Saline | + | D | 11.650e,g ± 3.0645 | 3.4 ± 4.9 |
8 | Right | IM CMVLacZ in 1.25% DMSO | + | A | 8.190e,f,g ± 1.9986 | |
9 | Left | IM CMVLacZ in LipoFECTAMINE | No EP | No EP | 0.0214b ± 0.0107 | |
10 | Right | IM CMVLacZ in LipoFECTAMINE | + | A | 0.0414b ± 0.1912 |